BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19583450)

  • 1. Idiopathic membranous nephropathy: management strategies.
    Quaglia M; Stratta P
    Drugs; 2009 Jul; 69(10):1303-17. PubMed ID: 19583450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of current and alternative therapies for idiopathic membranous nephropathy.
    Tran TH; J Hughes G; Greenfeld C; Pham JT
    Pharmacotherapy; 2015 Apr; 35(4):396-411. PubMed ID: 25884528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
    Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Membranous nephropathy: New insights in therapeutic approach].
    Dahan K
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S83-S87. PubMed ID: 28577748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
    McQuarrie EP; Stirling CM; Geddes CC
    Nephrol Dial Transplant; 2012 Jan; 27(1):235-42. PubMed ID: 21558430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic membranous nephropathy: diagnosis and treatment.
    Fervenza FC; Sethi S; Specks U
    Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus combined with corticosteroids versus Modified Ponticelli regimen in treatment of idiopathic membranous nephropathy: Randomized control trial.
    Ramachandran R; Hn HK; Kumar V; Nada R; Yadav AK; Goyal A; Kumar V; Rathi M; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrology (Carlton); 2016 Feb; 21(2):139-46. PubMed ID: 26205759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranous nephropathy in the older adult: epidemiology, diagnosis and management.
    Deegens JK; Wetzels JF
    Drugs Aging; 2007; 24(9):717-32. PubMed ID: 17727303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of idiopathic membranous nephropathy].
    Passerini P
    G Ital Nefrol; 2004; 21(6):531-9. PubMed ID: 15593020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic membranous nephropathy in children treated with rituximab: report of two cases.
    Malatesta-Muncher R; Eldin KW; Beck LH; Michael M
    Pediatr Nephrol; 2018 Jun; 33(6):1089-1092. PubMed ID: 29546599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic Membranous Nephropathy and Treatment Related Complications.
    Uncanin S; Dzemidzic J; Serdarevic N; Muslimovic A; Haskovic D
    Med Arch; 2020 Jun; 74(3):228-232. PubMed ID: 32801441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of immunosuppressive therapy in idiopathic membranous nephropathy.
    Maas R; Hofstra JM; Wetzels JF
    Minerva Med; 2012 Aug; 103(4):253-66. PubMed ID: 22805618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of the therapeutic approach to membranous nephropathy.
    Ponticelli C; Patrizia P; Del Vecchio L; Locatelli F
    Nephrol Dial Transplant; 2021 Apr; 36(5):768-773. PubMed ID: 32206786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF
    Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic membranous nephropathy: new therapeutic trends.
    Rostoker G
    Eur J Med; 1993 Feb; 2(2):106-16. PubMed ID: 8258013
    [No Abstract]   [Full Text] [Related]  

  • 18. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
    Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
    Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to Choose the Right Treatment for Membranous Nephropathy.
    Peritore L; Labbozzetta V; Maressa V; Casuscelli C; Conti G; Gembillo G; Santoro D
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.